Total Payments
$1,871
2024 Payments
$73.06
Companies
15
Transactions
140
Medicare Patients
175
Medicare Billing
$22,119
Payment Breakdown by Category
Food & Beverage$1,833 (97.9%)
Education$38.43 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,833 | 137 | 97.9% |
| Education | $38.43 | 3 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $421.70 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $243.19 | 24 | $0 (2020) |
| Allergan, Inc. | $216.76 | 16 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $210.01 | 26 | $0 (2021) |
| Alkermes, Inc. | $180.04 | 9 | $0 (2023) |
| AbbVie Inc. | $155.95 | 8 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $115.27 | 6 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $88.34 | 6 | $0 (2021) |
| Indivior Inc. | $81.52 | 6 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $41.38 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.06 | 3 | Neurocrine Biosciences, Inc. ($25.89) |
| 2023 | $131.27 | 6 | AbbVie Inc. ($80.22) |
| 2022 | $79.35 | 4 | Neurocrine Biosciences, Inc. ($24.18) |
| 2021 | $201.37 | 13 | AbbVie Inc. ($62.89) |
| 2020 | $293.20 | 18 | Ironshore Pharmaceuticals Inc. ($59.85) |
| 2019 | $342.03 | 27 | Alkermes, Inc. ($80.26) |
| 2018 | $486.48 | 45 | Janssen Pharmaceuticals, Inc ($148.16) |
| 2017 | $264.35 | 24 | Otsuka America Pharmaceutical, Inc. ($159.62) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Neuropsychiatry | ||||||
| 03/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: PSYCHIATRY | ||||||
| 01/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: CNS | ||||||
| 05/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: PSYCHIATRY | ||||||
| 03/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Neuropsychiatry | ||||||
| 01/12/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: CNS | ||||||
| 11/15/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: CNS | ||||||
| 06/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: CNS | ||||||
| 03/23/2021 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: BH | ||||||
| 03/22/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: CNS | ||||||
| 03/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: CNS | ||||||
| 01/25/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Central Nervous System | ||||||
| 01/18/2021 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 69 | $12,420 | $4,296 |
| 2022 | 1 | 18 | 62 | $11,160 | $4,787 |
| 2021 | 2 | 43 | 71 | $12,780 | $3,771 |
| 2020 | 3 | 94 | 259 | $36,320 | $9,265 |
Total Patients
175
Total Services
461
Medicare Billing
$22,119
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 69 | $12,420 | $4,296 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 62 | $11,160 | $4,787 | 42.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 44 | $7,920 | $3,181 | 40.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 27 | $4,860 | $590.44 | 12.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 41 | 103 | $18,640 | $4,748 | 25.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 76 | $13,680 | $3,809 | 27.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 80 | $4,000 | $709.04 | 17.7% |
About Dr. Mary Soderstrom, M.D
Dr. Mary Soderstrom, M.D is a Psychiatry healthcare provider based in Columbus, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427160704.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Soderstrom, M.D has received a total of $1,871 in payments from pharmaceutical and medical device companies, with $73.06 received in 2024. These payments were reported across 140 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,833).
As a Medicare-enrolled provider, Soderstrom has provided services to 175 Medicare beneficiaries, totaling 461 services with total Medicare billing of $22,119. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Columbus, TX
- Active Since 08/31/2006
- Last Updated 07/09/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1427160704
Products in Payments
- VRAYLAR (Drug) $372.71
- ABILIFY MAINTENA (Drug) $253.64
- LATUDA (Drug) $210.01
- INVEGA SUSTENNA (Drug) $200.14
- ARISTADA (Drug) $163.47
- REXULTI (Drug) $152.84
- INGREZZA (Drug) $115.27
- PERSERIS (Drug) $81.52
- JORNAY PM (Drug) $71.33
- HETLIOZ (Drug) $41.38
- AUSTEDO (Drug) $39.79
- CAPLYTA (Drug) $36.52
- ABILIFY ASIMTUFII (Drug) $24.25
- ABILIFY MYCITE (Drug) $20.00
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $17.01
- SPRAVATO (Drug) $16.85
- Aristada 441 mg (Drug) $16.57
- VYVANSE (Drug) $11.61
- INVEGA TRINZA (Drug) $8.21
- INVEGA (Drug) $4.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbus
Fred Romeo, Md, MD
Psychiatry — Payments: $2.3M
Psychiatry $2.3M
Michael Saribalas
Psychiatry — Payments: $1.3M
Psychiatry $1.3M
Kevin Ware, Md, MD
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Peter Zafirides, Md, MD
Psychiatry — Payments: $127,832
Psychiatry $127,832
Dr. Benjamin Roy, M.d, M.D
Psychiatry — Payments: $102,125
Psychiatry $102,125
Barbara Gracious, M.d, M.D
Psychiatry — Payments: $58,986
Psychiatry $58,986